Redox metals and oxidative abnormalities in human prion diseases

Acta Neuropathologica

Volumn 110, Issue 3, 2005, Pages 232-238

  Petersen, Robert B ^a   Siedlak, Sandra L ^a   Lee, Hyoung Gon ^a   Kim, Yong Sun ^b   Nunomura, Akihiko ^c   Tagliavini, Fabrizio ^d   Ghetti, Bernardino ^e   Cras, Patrick ^f   Moreira, Paula I ^g   Castellani, Rudy J ^h   Guentchev, Marin ⁱ   Budka, Herbert ⁱ   Ironside, James W ^j   Gambetti, Pierluigi ^a   Smith, Mark A ^a   Perry, George ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Hallym University   (South Korea)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

^e INDIANA UNIVERSITY   (United States)

^f UNIVERSITY OF ANTWERP   (Belgium)

^g UNIVERSITY OF COIMBRA   (Portugal)

^h MICHIGAN STATE UNIVERSITY   (United States)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^j UNIVERSITY OF EDINBURGH   (United Kingdom)

more..

Author keywords

Creutzfeld Jakob disease; Gerstmann Straussler Scheinker syndrome; Oxidative damage; Prion; Redox metals

Indexed keywords

8 HYDROXYGUANINE; AMYLOID BETA PROTEIN; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID; METAL DERIVATIVE; PRION PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DISEASE MARKER; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; MOUSE; NERVE CELL; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SCRAPIE;

ADULT; AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN; BIOLOGICAL MARKERS; BRAIN; CREUTZFELDT-JAKOB SYNDROME; FEMALE; GUANOSINE; HUMANS; MALE; METALS; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRION DISEASES; PRIONS;

EID: 26444549058     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-005-1034-4     Document Type: Article

References (42)

1. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, Bohlen A von, Schulz-Schaeffer W, Giese A, Westaway D, Kretzschmar H (1997) The cellular prion protein binds copper in vivo. Nature 390:684-687 9414160
2. Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Gullotta F, Haltia M, Hauw JJ, Ironside JW, Jellinger K (1995) Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5:459-466 8974629
3. Bugiani O, Giaccone G, Verga L, Pollo B, Frangione B, Farlow MR, Tagliavini F, Ghetti B (1993) Beta PP participates in PrP-amyloid plaques of Gerstmann-Straussler-Scheinker disease, Indiana kindred. J Neuropathol Exp Neurol 52:64-70 8093899
4. Castellani RJ, Harris PL, Sayre LM, Fujii J, Taniguchi N, Vitek MP, Founds H, Atwood CS, Perry G, Smith MA (2001) Active glycation in neurofibrillary pathology of Alzheimer disease: N (epsilon)-(carboxymethyl) lysine and hexitol-lysine. Free Radic Biol Med 31:175-180 10.1016/S0891-5849(01)00570-6
5. Castellani RJ, Perry G, Smith MA (2004) Prion disease and Alzheimer's disease: Pathogenic overlap. Acta Neurobiol Exp (Wars) 64:11-17
6. DeArmond SJ (2000) Cerebral amyloidosis in prion diseases. Amyloid 7:3-6 10842694
7. Fernaeus S, Halldin J, Bedecs K, Land T (2005) Changed iron regulation in scrapie-infected neuroblastoma cells. Brain Res Mol Brain Res 133:266-273 10.1016/j.molbrainres.2004.10.018
8. Ferrer I (1999) Nuclear DNA fragmentation in Creutzfeldt-Jakob disease: does a mere positive in situ nuclear end-labeling indicate apoptosis? Acta Neuropathol 97:5-12 9930889
9. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: Classification and characterisation. Br Med Bull 66:213-239 10.1093/bmb/66.1.213
10. Ghetti B, Tagliavini F, Masters CL, Beyreuther K, Giaccone G, Verga L, Farlow MR, Conneally PM, Dlouhy SR, Azzarelli B (1989) Gerstmann-Straussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 39:1453-1461 2573006
11. Ghetti B, Tagliavini F, Takao M, Bugiani O, Piccardo P (2003) Hereditary prion protein amyloidoses. Clin Lab Med 23:65-85, viii 10.1016/ S0272-2712(02)00064-1
12. Guentchev M, Wanschitz J, Voigtlander T, Flicker H, Budka H (1999) Selective neuronal vulnerability in human prion diseases. Fatal familial insomnia differs from other types of prion diseases. Am J Pathol 155:1453-1457 10550300
13. Guentchev M, Voigtlander T, Haberler C, Groschup MH, Budka H (2000) Evidence for oxidative stress in experimental prion disease. Neurobiol Dis 7:270-273 10964599
14. Guentchev M, Siedlak SL, Jarius C, Tagliavini F, Castellani RJ, Perry G, Smith MA, Budka H (2002) Oxidative damage to nucleic acids in human prion disease. Neurobiol Dis 9:275-281 10.1006/nbdi.2002.0477
15. Hall D, Edskes H (2004) Silent prions lying in wait: A two-hit model of prion/amyloid formation and infection. J Mol Biol 336:775-786 10.1016/ j.jmb.2003.12.004
16. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21:3017-3023 11312286
17. Honda K, Smith MA, Zhu X, Baus D, Merrick WC, Tartakoff AM, Hattier T, Harris PL, Siedlak SL, Fujioka H, Liu Q, Moreira PI, Miller FP, Nunomura A, Shimohama S, Perry G (2005) Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J Biol Chem [Mar 14; Epub ahead of print]
18. Ironside JW (2000) Pathology of variant Creutzfeldt-Jakob disease. Arch Virol Suppl (16):143-151
19. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM, Diringer H (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61:3688-3693 446004
20. Klatzo I, Gajdusek DC, Zigas V (1959) Pathology of Kuru. Lab Invest 8:799-847 13665963
21. Kubler E, Oesch B, Raeber AJ (2003) Diagnosis of prion diseases. Br Med Bull 66:267-279 10.1093/bmb/66.1.267
22. Lucas M, Izquierdo G, Munoz C, Solano F (1997) Internucleosomal breakdown of the DNA of brain cortex in human spongiform encephalopathy. Neurochem Int 31:241-244 10.1016/S0197-0186(96)00153-2
23. Mishra RS, Basu S, Gu Y, Luo X, Zou WQ, Mishra R, Li R, Chen SG, Gambetti P, Fujioka H, Singh N (2004) Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci 24:11280-11290 10.1523/JNEUROSCI.2864-04.2004
24. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19:1959-1964 10066249
25. Nunomura A, Perry G, Pappolla MA, Friedland RP, Hirai K, Chiba S, Smith MA (2000) Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol 59:1011-1017 11089579
26. Perry G, Sayre LM, Atwood CS, Castellani RJ, Cash AD, Rottkamp CA, Smith MA (2002) The role of iron and copper in the aetiology of neurodegenerative disorders: Therapeutic implications. CNS Drugs 16:339-352 11994023
27. Piccardo P, Ghetti B, Dickson DW, Vinters HV, Giaccone G, Bugiani O, Tagliavini F, Young K, Dlouhy SR, Seiler C, et al (1995) Gerstmann-Straussler-Scheinker disease (PRNP P102L): Amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165. J Neuropathol Exp Neurol 54:790-801 7595652
28. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363-13383 10.1073/ pnas.95.23.13363
29. Rachidi W, Vilette D, Guiraud P, Arlotto M, Riondel J, Laude H, Lehmann S, Favier A (2003) Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem 278:9064-9072 10.1074/jbc.M211830200
30. Roucou X, Gains M, LeBlanc AC (2004) Neuroprotective functions of prion protein. J Neurosci Res 75:153-161 10.1002/jnr.10864
31. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68:2092-2097 9109537
32. Sayre LM, Perry G, Smith MA (1999) In situ methods for detection and localization of markers of oxidative stress: Application in neurodegenerative disorders. Methods Enzymol 309:133-152 10507022
33. Sayre LM, Perry G, Atwood CS, Smith MA (2000) The role of metals in neurodegenerative diseases. Cell Mol Biol (Noisy-le-grand) 46:731-741
34. Sigurdsson EM, Brown DR, Alim MA, Scholtzova H, Carp R, Meeker HC, Prelli F, Frangione B, Wisniewski T (2003) Copper chelation delays the onset of prion disease. J Biol Chem 278:46199-46202 10.1074/ jbc.C300303200
35. Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Chader GJ, Wiggert B, Petersen RB, Perry G (1994) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 145:42-47 8030754
36. Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94:9866-9868 10.1073/pnas.94.18.9866
37. Thackray AM, Knight R, Haswell SJ, Bujdoso R, Brown DR (2002) Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem J 362:253-258 11829763
38. Wong BS, Chen SG, Colucci M, Xie Z, Pan T, Liu T, Li R, Gambetti P, Sy MS, Brown DR (2001) Aberrant metal binding by prion protein in human prion disease. J Neurochem 78:1400-1408 10.1046/j.1471-4159.2001.00522.x
39. Wong BS, Liu T, Li R, Pan T, Petersen RB, Smith MA, Gambetti P, Perry G, Manson JC, Brown DR, Sy MS (2001) Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 76:565-572 10.1046/j.1471-4159.2001.00028.x
40. Wong BS, Liu T, Paisley D, Li R, Pan T, Chen SG, Perry G, Petersen RB, Smith MA, Melton DW, Gambetti P, Brown DR, Sy MS (2001) Induction of HO-1 and NOS in doppel-expressing mice devoid of PrP: Implications for doppel function. Mol Cell Neurosci 17:768-775 11312611
41. Zhu X, Castellani RJ, Takeda A, Nunomura A, Atwood CS, Perry G, Smith MA (2001) Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: The 'two hit' hypothesis. Mech Ageing Dev 123:39-46 10.1016/S0047-6374(01)00342-6
42. Zhu X, Raina AK, Perry G, Smith MA (2004) Alzheimer's disease: The two-hit hypothesis. Lancet Neurol 3:219-226 10.1016/S1474-4422(04)00707-0